Related Experiment Videos
Microarray-based classification of diffuse large B-cell lymphoma.
Christian Bjørn Poulsen1, Rehannah Borup, Finn Cilius Nielsen
1Department of Pathology, Copenhagen University Hospital, Rigshospitalet, Denmark. c.poulsen@rh.dk
European Journal of Haematology
|May 7, 2005
Summary
Gene expression profiling effectively classifies diffuse large B-cell lymphoma (DLBCL) into distinct subtypes, Germinal Center B-cell (GCB) and Activated B-cell (ABC), using standardized Affymetrix Genechips for improved clinical management.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gene expression profiling has previously classified diffuse large B-cell lymphoma (DLBCL) into Germinal Center B-cell (GCB) and Activated B-cell (ABC) subtypes.
- Cross-platform validation is crucial for reliable classification and clinical application.
Purpose of the Study:
- To validate the feasibility of classifying DLBCL subtypes using Affymetrix HG-U133A oligonucleotide arrays.
- To improve the accuracy of DLBCL classification through gene expression profiling.
Main Methods:
- Hierarchical clustering was performed on gene expression profiles of 52 primary nodal DLBCL samples.
- Previously published gene lists were adapted to HG-U133A probe sets for initial classification.
- An improved set of 78 classifier genes was generated and validated on existing datasets.
Main Results:
- Three subtypes were distinguished: GCB (n=20), ABC (n=25), and an intermediate Type-3 (n=5).
- GCB patients showed better initial response to CHOP/CHOP-like regimens and had less advanced disease.
- The novel 78-gene classifier demonstrated higher specificity than previous gene lists.
Conclusions:
- Gene expression profiling using Affymetrix Genechips efficiently distinguishes GCB and ABC subtypes of DLBCL, suggesting distinct biological entities.
- The standardized Genechip platform is suitable for prospective studies to integrate gene expression profiling into DLBCL clinical management.